Tyler C W, Lee N C, Robboy S J, Kurman R J, Paris A L, Wingo P A, Williamson G D
Office of the Director, Centers for Disease Control, Atlanta, GA 30333.
Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):65-70. doi: 10.1016/0002-9378(91)90628-5.
The Cancer and Steroid Hormone Study, a multicenter, population-based, case-control study of ovarian, breast, and endometrial cancer in women 20 to 54 years of age, permitted the diagnoses of contributing pathologists to be compared with those of a panel of three gynecologic pathologists. A diagnosis of ovarian cancer was made by contributing pathologists on 477 subjects. Agreement between the two groups of pathologists was 97% for primary epithelial ovarian cancer and 89% for primary nonepithelial ovarian malignancies. Agreement on diagnosis of major cellular subtypes of ovarian malignancy ranged between 73% for endometrioid cancer and 100% for clear cell carcinomas. We conclude that the diagnosis of pathologic features of primary ovarian cancer is highly predictable. Nonetheless, diagnosis by histologic type varies sufficiently that a review process should be considered for clinical or investigative decisions involving specific histologic diagnoses of ovarian cancer.
癌症与类固醇激素研究是一项针对20至54岁女性卵巢癌、乳腺癌和子宫内膜癌的多中心、基于人群的病例对照研究,该研究使得参与研究的病理学家所做出的诊断能够与由三位妇科病理学家组成的专家组的诊断进行比较。参与研究的病理学家对477名受试者做出了卵巢癌诊断。两组病理学家之间对于原发性上皮性卵巢癌的诊断一致性为97%,对于原发性非上皮性卵巢恶性肿瘤的诊断一致性为89%。关于卵巢恶性肿瘤主要细胞亚型诊断的一致性在子宫内膜样癌的73%至透明细胞癌的100%之间。我们得出结论,原发性卵巢癌病理特征的诊断具有高度可预测性。尽管如此,不同组织学类型的诊断差异足够大,对于涉及卵巢癌特定组织学诊断的临床或研究决策,应考虑进行复查流程。